## [Lisbane Medical Centre](/uk-en/about/partnerships/collaborative-working/lisbane-medical-centre "Lisbane Medical Centre") Executive summary **Project Name:** Northern Ireland General Practice Heart Failure QOF Register Review Collaborative Working **Project Summary:** The Collaborative working project will improve the accuracy of read coding for existing Heart Failure patients and aim to find those with a missing diagnosis through reviewing patients who have Heart Failure associated risk factors. The benefits include data cleansing and validation of the Heart Failure QOF registers, increasing QOF outcome generation and ultimately, this benefit patients through better diagnosis, review and improved management. As part of the Project, ICS are performing register reviews in 12 GP practices across Northern Ireland, with Lisbane Medical Centre being one of these. The practice will provide Interface Clinical Services (“ICS”) with access to all patient records within the GP Practice to facilitate the Heart Failure QOF register review. Using the report provided by ICS, the practice will review all appropriate patient records and create a Heart Failure management plan for each patient to improve their Heart Failure care. Services provided by ICS will be funded by Novartis. **Planned Milestones:** *Milestones with Lisbane Medical Centre* Milestone Milestone Date **Generation of ICS report** 1 month post project initiation **Completion of Consultation day by practice Heart Failure MDT** 1 month after completion of register review by ICS *Overall Project Summary* Milestone Milestone Date **Group 1** **(Practices 1, 2 & 3) complete database review** 3 months after Project initiation, 3 months after practices signs individual CWA **Group 1** **(Practices 1, 2 & 3) complete Consultation Day** 4 months after Project initiation, 4 months after practices signs individual CWA **Group 2** **(Practices 4, 5 & 6) complete database review** 6 months after Project initiation, 3 months after practices signs individual CWA **Group 2** **(Practices 4, 5 & 6) complete Consultation Day** 7 months after Project initiation, 4 months after practices signs individual CWA **Group 3** **(7, 8 & 9) complete database review** 9 months after Project initiation, 3 months after practices signs individual CWA **Group 3** **(7, 8 & 9) complete Consultation Day** 10 months after Project initiation, 4 months after practices signs individual CWA **Group 4** **(10, 11 & 12) complete database review** 12 months after Project initiation, 3 months after practices signs individual CWA **Group 4** **(10, 11 & 12) complete Consultation Day** 13 months after Project initiation, 4 months after practices signs individual CWA **Expected Benefits:** *The benefits to the patient include:* - Proactive assessment and earlier detection of Heart Failure - Greater opportunity for initiation and optimisation of evidence-based Heart Failure therapies - Improvement in quality of care - Improved experience of the Heart Failure service *The benefits to the relevant NHS GP practice include:* - data cleansing and validation of QOF - increasing QOF outcome generation *The benefits to Novartis include:* - Creation of more opportunities for the appropriate use of cardiology licensed medicines in line with NICE and clinical guidelines, including Novartis’ medicine - Better understanding of customers’ and patients’ needs specific to the management of Heart Failure but indeed more widely - Greater insight into the practical challenges and workings of delivering a high quality and sustainable Heart Failure Service - Improved reputation **Start Date & Duration:** **Lisbane Medical Centre** Start date: February 2023 Duration: 2 months from commencement of services being provided by ICS **Overall Collaborative Working Project** Start date: April 2022 Duration: up to 13 months UK2302129493 Outcomes summary **Project Name:** Northern Ireland General Practice Heart Failure QOF Register Review Collaborative Working **Partner Organisation(s):** Lisbane Medical Centre **Completion Date:** May 2023 **Outcome Summary:** The Collaborative working has improved the accuracy of read coding for existing Heart Failure patients and found those with a missing diagnosis through reviewing patients who have Heart Failure associated risk factors. **Outcomes:** Percentage increase of patients added to the HF register: 42% Patients added to HF register: 15 Increase of patients receiving NICE recommended therapy: No data available Number of patients referred into secondary care: 0 Increase in local HF prevalence above national prevalence: Baseline HF prevalence: 0.8% End of project HF prevalence: 1.2% National HF prevalence: 1-2% **Conclusion:** The Collaborative working has improved the identification of Heart Failure patients and found those with a missing diagnosis which should improve the outcomes of these patients. FA-11364789 | February 2025